Matinas BioPharma Holdings, Inc. — Form D

Matinas BioPharma Holdings, Inc. of BEDMINSTER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-07. The offering totals $15.0M, of which $7.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Jerome A JabbourDirectorBedminster, NJ
Robin SmithDirectorBEDMINSTER, NJ
Eric EndeDirectorBEDMINSTER, NJ
Jerome JabbourDirectorBEDMINSTER, NJ
Jerome JabbourExecutive OfficerBEDMINSTER, NJ
Evelyn D'AnDirectorBEDMINSTER, NJ
Keith KucinskiExecutive OfficerBEDMINSTER, NJ
Matthew WiklerDirectorBEDMINSTER, NJ
Natasha GiordanoDirectorHoboken, NJ
Roelof RongenDirectorDelray Beach, FL
Roelof RongenExecutive OfficerDelray Beach, FL
Abdel A FawzyExecutive OfficerBedminster, NJ
James F ScibettaDirectorBedminster, NJ
Jerome A JabbourExecutive OfficerBedminster, NJ
Douglas F KlingExecutive OfficerBedminster, NJ
Stefano A FerrariDirectorBedminster, NJ
Herbert A ConradDirectorBedminster, NJ
Adam A SternDirectorBedminster, NJ
Gary A GaglioneExecutive OfficerBedminster, NJ
George BobotasExecutive OfficerBedminster, NJ
STEPHEN P HARRINGTONDirectorPLYMOUTH MEETING, PA
STEPHEN P HARRINGTONExecutive OfficerPLYMOUTH MEETING, PA
Raphael J ManninoExecutive OfficerTampa, FL

Other filings by this issuer (5)

FiledFormOfferingSold
2025-02-19D$3.3M$1.6M
2017-01-26D$15.5M$15.5M
2016-08-12D$8.0M$4.4M
2015-04-13D$10.0M$10.0M
2013-07-25D$385K$385K

More